TY  - BOOK
AU  - Agudelo,Carlos Andrés
AU  - Anaya,Juan Manuel
AU  - Matute,Gustavo
AU  - Pineda-Tamayo,Ricardo
AU  - Porras,Alvaro
AU  - Rojas-Villarraga,Adriana
TI  - Tuberculosis in patientes treated with tumor necrosis factor-alpha antagonists living in an endemic area. Is the risk worthwhile?
CY  - Bogotá, D. C
KW  - Tuberculosis
KW  - Enfermedades endémicas
KW  - Factor de necrosis tumoral alfa
KW  - Colombia
N2  - Tumor necrosis factor alpha antagonists (TNFA) are biological agents to treat chronic inflammatory and autoimmune diseases. However, their use is associated with an increased rate of tuberculosis, endemic mycoses, and intracellular bacterial infections. S
ER  -